Literature DB >> 9756337

Dystrophin deficient myotubes undergo apoptosis in mouse primary muscle cell culture after DNA damage.

M Sandri1, M L Massimino, M Cantini, E Giurisato, C Sandri, P Arslan, U Carraro.   

Abstract

Apoptosis has been demonstrated to occur in differentiated myocardial muscle, neonatal skeletal muscle and skeletal myoblasts in response to injury. In this report, we studied differentiated normal and dystrophin deficient murine skeletal muscle cell cultures that have been injured by a pulse of cis-platinum (2 h). Forty-eight hours after DNA damage, dystrophin positive myotubes appeared almost normal though some myoblasts showed DNA fragmentation. On the other hand, dystrophin deficient myotubes presented progressive degeneration via apoptosis detected either by TUNEL or by nuclear morphology. Degeneration of mdx muscle fibers was confirmed by counting both the number of myotubes observed by contrast phase microscopy and myonuclei viewed by immunoreaction for MyoD. A 6-fold decrease in the number of muscle cells was observed in the dystrophin-deficient cell culture compared to the parental culture (P < 0.001). Direct evidence of degenerating myotubes displaying MyoD- and TUNEL-positive nuclei was obtained. Like myoblasts, differentiated dystrophin deficient myotubes were able to degenerate via apoptosis, showing that mature dystrophin deficient cells are fragile and undergo apoptosis when subjected to a mild injury which would normally be repaired in parental cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9756337     DOI: 10.1016/s0304-3940(98)00563-1

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

Review 1.  Apoptosis of skeletal muscle cells and the pathogenesis of myositis: a perspective.

Authors:  C C Liu; J M Ahearn
Journal:  Curr Rheumatol Rep       Date:  2001-08       Impact factor: 4.592

2.  SLIMMER (FHL1B/KyoT3) interacts with the proapoptotic protein Siva-1 (CD27BP) and delays skeletal myoblast apoptosis.

Authors:  Denny L Cottle; Meagan J McGrath; Brendan R Wilding; Belinda S Cowling; Jordan M Kane; Colleen E D'Arcy; Melissa Holdsworth; Irene Hatzinisiriou; Mark Prescott; Susan Brown; Christina A Mitchell
Journal:  J Biol Chem       Date:  2009-07-29       Impact factor: 5.157

3.  Investigation of Debio 025, a cyclophilin inhibitor, in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy.

Authors:  J Reutenauer; O M Dorchies; O Patthey-Vuadens; G Vuagniaux; U T Ruegg
Journal:  Br J Pharmacol       Date:  2008-07-21       Impact factor: 8.739

4.  Loss of cIAP1 attenuates soleus muscle pathology and improves diaphragm function in mdx mice.

Authors:  Emeka K Enwere; Louise Boudreault; Janelle Holbrook; Kristen Timusk; Nathalie Earl; Eric LaCasse; Jean-Marc Renaud; Robert G Korneluk
Journal:  Hum Mol Genet       Date:  2012-11-25       Impact factor: 6.150

5.  Over-expression of BCL2 rescues muscle weakness in a mouse model of oculopharyngeal muscular dystrophy.

Authors:  Janet E Davies; David C Rubinsztein
Journal:  Hum Mol Genet       Date:  2011-01-03       Impact factor: 6.150

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.